1.44 - 1.45
1.18 - 2.36
71.0K / 1.73M (Avg.)
-18.12 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth above 1.5x 0315.HK's 5.71%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-100.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-100.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-101.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-101.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-89.25%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-309.88%
Negative OCF growth while 0315.HK is at 70.30%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-54.96%
Negative FCF growth while 0315.HK is at 209.33%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-99.58%
Negative 10Y revenue/share CAGR while 0315.HK stands at 335.84%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.16%
Negative 5Y CAGR while 0315.HK stands at 278.73%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-99.62%
Negative 3Y CAGR while 0315.HK stands at 96.67%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-173.07%
Negative 10Y OCF/share CAGR while 0315.HK stands at 217.29%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-178.15%
Negative 5Y OCF/share CAGR while 0315.HK is at 187.43%. Joel Greenblatt would question the firm’s operational model or cost structure.
-168.71%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-105.22%
Negative 10Y net income/share CAGR while 0315.HK is at 49.96%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-127.49%
Negative 5Y net income/share CAGR while 0315.HK is 1474.60%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-106.83%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
536.80%
Stable or rising dividend while 0315.HK is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
988.65%
5Y dividend/share CAGR above 1.5x 0315.HK's 119.18%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
33.80%
3Y dividend/share CAGR at 50-75% of 0315.HK's 48.46%. Martin Whitman might see a weaker short-term approach to distributing cash.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.95%
We have a declining book value while 0315.HK shows 3.06%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.